Drug · DIN 02563509
IMAAVY
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 23, 2026; first marketed January 23, 2026.
- Drug Identification Number (DIN)
- 02563509
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Nipocalimab L04AL03
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NIPOCALIMAB | 300 MG | 1.62 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 5, 2025: NOC 36540New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “imaavy”. A notice may cover another product or only some lots: read it to see what it covers.
- IMAAVY: Affected lots may contain glass particlesSeptember 21, 2026 · Biologic or vaccine · Product quality · Type II
Other DINs named IMAAVY
- DIN 02563517 · Marketed